CRISPR Therapeutics AG (NASDAQ:CRSP)

64.62
Delayed Data
As of 4:00pm ET
 -2.32 / -3.47%
Today’s Change
42.51
Today|||52-Week Range
114.23
-14.73%
Year-to-Date

Stock Price Forecast

The 22 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 103.50, with a high estimate of 220.00 and a low estimate of 50.00. The median estimate represents a +60.17% increase from the last price of 64.62.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in CRISPR Therapeutics AG. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$2.29
Sales
$1.8M
Reporting Date
Nov 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.46%
 
 
 
 
 
 
Growthannually -295.00%
 
 
 
 
 
 

Sales

Growthquarterly 1,069.21%
 
 
 
 
 
 
Growthannually -99.13%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.